Description
API: Pegaspargase. Indications: Pegaspargase Injection is indicated for the treatment of acute lymphocytic leukaemia (ALL), non-Hodgkin’s lymphoma.
Pegaspargase, is a medication used in the treatment of acute lymphoblastic leukemia (ALL). Often it is used together with anthracycline, vincristine, and corticosteroids (for example prednisone and dexamethasone). Pegaspargase can be administered either via an intravenous infusion or a intramuscular injection.
Secure & Compliant Supply of Pegaspargase Injection from Aark Pharmaceuticals
As healthcare networks across Europe and the Middle East continuously seek reliable access to critical life-saving oncology therapeutics, Aark Pharmaceuticals is reaching out to offer a seamless, GDP-compliant supply channel for Pegaspargase Injection (Single-use vials, 3,750 IU / 5 mL).





